









Mercado
/
Acciones
/
nasdaq-bsx
/

Boston Scientific Corp

BSX

102.690USD

-2.290-2.18%

Cierre 11/14, 16:00（ET）Cotizaciones retrasadas 15 min

152.22BCap. mercado

54.54P/E TTM



Boston Scientific Corp

102.690

-2.290-2.18%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Boston Scientific Corp Compañía

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.

Información de Boston Scientific Corp



Símbolo de cotizaciónBSX

Nombre de la empresaBoston Scientific Corp

Fecha de salida a bolsaMay 19, 1992

Director ejecutivoMr. Michael F. (Mike) Mahoney

Número de empleados53000

Tipo de seguridadOrdinary Share

Fin del año fiscalMay 19

Dirección300 Boston Scientific Way

CiudadMARLBOROUGH

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal01752-1234

Teléfono15086834000

Sitio Webhttps://www.bostonscientific.com/en-US/Home.html

Símbolo de cotizaciónBSX

Fecha de salida a bolsaMay 19, 1992

Director ejecutivoMr. Michael F. (Mike) Mahoney

Ejecutivos de Boston Scientific Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Ms. Ellen M. Zane

Independent Director

24.13K

-34.82%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-58.23%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

Mr. Edward J. Ludwig

Lead Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Ms. Ellen M. Zane

Independent Director

24.13K

-34.82%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Electrophysiology

840.00M

16.60%

Endoscopy

737.00M

14.56%

Interventional Cardiology Therapies

731.00M

14.44%

Peripheral Interventions

698.00M

13.79%

Urology

676.00M

13.36%

Otro

1.38B

27.25%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

3.22B

63.70%

EMEA (Europe, Middle East and Africa)

878.00M

17.35%

Asia Pacific

790.00M

15.61%

Latin America and Canada

169.00M

3.34%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Electrophysiology

840.00M

16.60%

Endoscopy

737.00M

14.56%

Interventional Cardiology Therapies

731.00M

14.44%

Peripheral Interventions

698.00M

13.79%

Urology

676.00M

13.36%

Otro

1.38B

27.25%

Estadísticas de accionistas

Actualizado: sáb., 8 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

9.28%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

Otro

72.63%

Accionistas

Proporción

The Vanguard Group, Inc.

9.28%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

Otro

72.63%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

50.65%

Investment Advisor/Hedge Fund

30.26%

Hedge Fund

4.19%

Pension Fund

2.92%

Research Firm

2.44%

Bank and Trust

1.87%

Sovereign Wealth Fund

1.54%

Family Office

0.23%

Private Equity

0.21%

Otro

5.69%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

2840

1.40B

94.18%

+558.00K

2025Q2

2752

1.39B

93.57%

+165.36K

2025Q1

2744

1.39B

93.81%

-5.31M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

136.47M

9.21%

+2.53M

+1.89%

Jun 30, 2025

Fidelity Management & Research Company LLC

99.47M

6.71%

-17.98M

-15.31%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

78.19M

5.28%

+380.40K

+0.49%

Jun 30, 2025

State Street Investment Management (US)

65.19M

4.4%

+713.38K

+1.11%

Jun 30, 2025

PRIMECAP Management Company

34.66M

2.34%

-1.83M

-5.03%

Jun 30, 2025

Geode Capital Management, L.L.C.

32.42M

2.19%

+622.60K

+1.96%

Jun 30, 2025

Capital World Investors

28.52M

1.93%

-33.95K

-0.12%

Jun 30, 2025

Managed Account Advisors LLC

22.05M

1.49%

+765.61K

+3.60%

Jun 30, 2025

The Bollard Group, LLC

20.08M

1.36%

-411.38K

-2.01%

Jun 30, 2025

Norges Bank Investment Management (NBIM)

19.46M

1.31%

-275.11K

-1.39%

Jun 30, 2025

ETFs relacionados



Actualizado: jue., 6 de nov

Nombre

Proporción

iShares U.S. Medical Devices ETF

11.98%

Goldman Sachs Future Health Care Equity ETF

7.69%

Invesco Dorsey Wright Healthcare Momentum ETF

4.06%

JPMorgan Healthcare Leaders ETF

3.67%

Tema Heart & Health ETF

3.64%

Segall Bryant & Hamill Select Equity ETF

3.46%

Parnassus Core Select ETF

2.95%

Health Care Select Sector SPDR Fund

2.87%

Proshares Ultra Health Care

2.86%

Knowledge Leaders Developed World ETF

2.85%

iShares U.S. Medical Devices ETF

Proporción11.98%

Goldman Sachs Future Health Care Equity ETF

Proporción7.69%

Invesco Dorsey Wright Healthcare Momentum ETF

Proporción4.06%

JPMorgan Healthcare Leaders ETF

Proporción3.67%

Tema Heart & Health ETF

Proporción3.64%

Segall Bryant & Hamill Select Equity ETF

Proporción3.46%

Parnassus Core Select ETF

Proporción2.95%

Health Care Select Sector SPDR Fund

Proporción2.87%

Proshares Ultra Health Care

Proporción2.86%

Knowledge Leaders Developed World ETF

Proporción2.85%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

